Global Fexofenadine Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fexofenadine Hydrochloride Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Fexofenadine Hydrochloride is an antihistamine used to treat allergic symptoms of seasonal allergic rhinitis (sneezing, runny nose, itchy or watery eyes), and urticaria (hives).
Fexofenadine Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fexofenadine Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Seasonal Allergic Rhinitis and Urticaria are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Fexofenadine Hydrochloride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Fexofenadine Hydrochloride key manufacturers include Viruj, JRC, Sumitomo Chemical, Sibram, Apintus Labs, Hainan Shatingning Pharmaceutical, Hainan Wante Pharmaceutical, Jiangsu Diyi Pharmaceutical and Chizhou Dongsheng Pharmaceutical, etc. Viruj, JRC, Sumitomo Chemical are top 3 players and held % sales share in total in 2022.
Fexofenadine Hydrochloride can be divided into Purity98% and PurityAbove 98%, etc. Purity98% is the mainstream product in the market, accounting for % sales share globally in 2022.
Fexofenadine Hydrochloride is widely used in various fields, such as Seasonal Allergic Rhinitis and Urticaria, etc. Seasonal Allergic Rhinitis provides greatest supports to the Fexofenadine Hydrochloride industry development. In 2022, global % sales of Fexofenadine Hydrochloride went into Seasonal Allergic Rhinitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fexofenadine Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Viruj
JRC
Sumitomo Chemical
Sibram
Apintus Labs
Hainan Shatingning Pharmaceutical
Hainan Wante Pharmaceutical
Jiangsu Diyi Pharmaceutical
Chizhou Dongsheng Pharmaceutical
Segment by Type
Purity98%
PurityAbove 98%
Seasonal Allergic Rhinitis
Urticaria
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fexofenadine Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fexofenadine Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fexofenadine Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fexofenadine Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fexofenadine Hydrochloride introduction, etc. Fexofenadine Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fexofenadine Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Fexofenadine Hydrochloride report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fexofenadine Hydrochloride market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Seasonal Allergic Rhinitis and Urticaria are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Fexofenadine Hydrochloride industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Fexofenadine Hydrochloride key manufacturers include Viruj, JRC, Sumitomo Chemical, Sibram, Apintus Labs, Hainan Shatingning Pharmaceutical, Hainan Wante Pharmaceutical, Jiangsu Diyi Pharmaceutical and Chizhou Dongsheng Pharmaceutical, etc. Viruj, JRC, Sumitomo Chemical are top 3 players and held % sales share in total in 2022.
Fexofenadine Hydrochloride can be divided into Purity98% and PurityAbove 98%, etc. Purity98% is the mainstream product in the market, accounting for % sales share globally in 2022.
Fexofenadine Hydrochloride is widely used in various fields, such as Seasonal Allergic Rhinitis and Urticaria, etc. Seasonal Allergic Rhinitis provides greatest supports to the Fexofenadine Hydrochloride industry development. In 2022, global % sales of Fexofenadine Hydrochloride went into Seasonal Allergic Rhinitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fexofenadine Hydrochloride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Viruj
JRC
Sumitomo Chemical
Sibram
Apintus Labs
Hainan Shatingning Pharmaceutical
Hainan Wante Pharmaceutical
Jiangsu Diyi Pharmaceutical
Chizhou Dongsheng Pharmaceutical
Segment by Type
Purity98%
PurityAbove 98%
Segment by Application
Seasonal Allergic Rhinitis
Urticaria
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fexofenadine Hydrochloride market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fexofenadine Hydrochloride, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fexofenadine Hydrochloride industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Fexofenadine Hydrochloride in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fexofenadine Hydrochloride introduction, etc. Fexofenadine Hydrochloride Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Fexofenadine Hydrochloride market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices